February 20, 2018 / 1:32 PM / 10 months ago

BRIEF-Nuuvera Amends Arrangement Agrees To Acquire Remaining Interest In Avanti Rx Analytics

Feb 20 (Reuters) - Nuuvera Inc:

* NUUVERA AMENDS ARRANGEMENT; AGREES TO ACQUIRE REMAINING INTEREST IN AVANTI RX ANALYTICS

* NUUVERA AMENDS ARRANGEMENT; AGREES TO ACQUIRE REMAINING INTEREST IN AVANTI RX ANALYTICS

* ‍TOTAL CONSIDERATION FOR AVANTI TRANSACTION IS EXPECTED TO BE APPROXIMATELY $43 MILLION​

* DEAL CONSIDERATION HAS BEEN REDUCED TO $0.60 IN CASH, 0.3546 OF AN APHRIA SHARE FOR EACH NUUVERA SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below